Cite
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia
MLA
Ruud Delwel, et al. “Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.” Cancer Discovery, vol. 11, no. 11, Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4fb3dbdca13f4f0ef37917d89572b412&authtype=sso&custid=ns315887.
APA
Ruud Delwel, Eric M.J. Bindels, Sophie Ottema, Marije Havermans, Emery H. Bresnick, François G. Kavelaars, Andrea Arricibita Varea, Johannes Zuber, Alex Kentsis, Remco Hoogenboezem, Anja Ebert, Roger Mulet-Lazaro, Tim Grob, Daniel R. Matson, Dorien Pastoors, Michaela Fellner, Stanley van Herk, Claudia A.J. Erpelinck-Verschueren, & Leonie Smeenk. (2020). Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia. Cancer Discovery, 11(11).
Chicago
Ruud Delwel, Eric M.J. Bindels, Sophie Ottema, Marije Havermans, Emery H. Bresnick, François G. Kavelaars, Andrea Arricibita Varea, et al. 2020. “Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.” Cancer Discovery 11 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4fb3dbdca13f4f0ef37917d89572b412&authtype=sso&custid=ns315887.